This past Friday, the iBio (NYSEAMERICAN:IBIO) stock emerged as one of the notable gainers and it is likely that the stock is going to be on the radars of many investors this week.
Over the course of the past week alone, the stock has gained 30% and also managed to gain considerable momentum. The latest rally in the stock has come about after the company announced its plans for the development of a second-generation COVID 19 vaccine candidate.
It goes without saying that it is an intriguing project and it seems that investors have also been suitably intrigued. The company is looking to target N protein and eventually develop a new COVID 19 vaccine that is going to be effective in guarding against the new strains of the virus. The company did state that there is strong competition in this particular space but a new vaccine might still find its place in the market.
Editor and Computer Expert
A hardcore tech enthusiast and computer expert Uson Abdilazhanov who holds a degree in communications started writing in his personal blogs since 2012. That time he was interested in the technical part of the computer. But now the software aspect plays an important role in his career. Currently, he runs a PC building and repairing shop which helps a lot of designers and gamers who always like to try new things.